8.20
price down icon0.49%   -0.04
after-market After Hours: 8.20
loading

Lexeo Therapeutics Inc Stock (LXEO) Forecast

The Lexeo Therapeutics Inc (LXEO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.71, representing a +140.36% increase from the current price of $8.20. The highest analyst price target is $22.12, and the lowest is $17.30.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LXEO Price Target
Average 22.06 (+169.05% Upside)
loading

Is Lexeo Therapeutics Inc (LXEO) A Buy Now?

Oscillators
Name Value Action
RSI(14) 77.00 Sell
STOCH(9,6) 70.70 Neutral
STOCHRSI(14) 60.61 Neutral
MACD(12,26) 0.7866 Buy
ADX(14) 45.89 Buy
William %R -18.74 Sell
CCI(14) 70.43 Neutral
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
7.408
Buy
7.5348
Buy
MA20
6.6195
Buy
6.873
Buy
MA50
5.5636
Buy
5.8634
Buy
MA100
4.7493
Buy
5.2292
Buy
MA200
4.3982
Buy
5.8043
Buy
Buy: 10 Sell: 0 Neutral: 0
Summary: Buy
According to our latest analysis, LXEO could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on LXEO, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 77 indicates that LXEO is overbought. This suggests that LXEO price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
  2. STOCH (Stochastic Oscillator): The STOCH value of 70.7 indicates that LXEO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 60.61 indicates that LXEO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 45.89 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 70.43 indicates that LXEO is still overbought but not to an extreme extent.

Long-term LXEO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lexeo Therapeutics Inc financial reports and earnings history, Lexeo Therapeutics Inc (LXEO) stock could reach $32.05 by 2030, $61.21 by 2040 and $92.26 by 2050. See the projected annual prices until 2050 of the Lexeo Therapeutics Inc stock below:

  • Lexeo Therapeutics Inc (LXEO) is expected to reach an average price of $46.72 in 2035, with a high prediction of $48.43 and a low estimate of $43.90. This indicates an $469.81% rise from the last recorded price of $8.20.
  • Lexeo Therapeutics Inc (LXEO) stock is projected to chart a bullish course in 2040, with an average price target of $60.17, representing an $633.78% surge from its current level. The forecast ranges from a conservative $56.46 to a sky-high $61.21.
  • Our analysts predict Lexeo Therapeutics Inc (LXEO) to jump 723.47% by 2045, soaring from $65.56 to an average price of $67.52, potentially reaching $75.25. While $65.56 is the low estimate, the potential upside is significant.
  • Lexeo Therapeutics Inc (LXEO) stock is expected to climb by 2050, reaching an average of $89.97, a $997.23% jump from its current level. However, a wide range of estimates exists, with high and low targets of $92.26 and $87.14, respectively, highlighting the market's uncertainty.

Lexeo Therapeutics Inc Stock (LXEO) Year by Year Forecast

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2025

Lexeo Therapeutics Inc Stock (LXEO) is expected to reach an average price of $20.13 in 2025, with a high prediction of $27.13 and a low estimate of $13.13. This indicates an +145.44% rise from the last recorded price of $8.20.
Month Average Low High Change from today's price
November, 2025 $20.58 $17.30 $22.12 +150.98%
December, 2025 $17.17 $16.69 $21.23 +109.36%

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2026

The predicted value for Lexeo Therapeutics Inc (LXEO) in 2026 is set at an average of $22.86. Estimates vary from a peak of $30.32 to a trough of $15.40, indicating an +178.80% surge from the present price of $8.20.
Month Average Low High Change from today's price
January, 2026 $16.86 $15.40 $18.49 +105.61%
February, 2026 $21.54 $15.49 $22.19 +162.74%
March, 2026 $19.73 $16.25 $23.94 +140.59%
April, 2026 $23.59 $18.55 $28.72 +187.70%
May, 2026 $21.76 $21.21 $24.11 +165.31%
June, 2026 $22.25 $18.96 $23.79 +171.34%
July, 2026 $18.87 $18.39 $22.91 +130.16%
August, 2026 $18.38 $16.92 $20.21 +124.15%
September, 2026 $19.37 $17.02 $25.49 +136.20%
October, 2026 $22.40 $17.81 $24.94 +173.19%
November, 2026 $25.20 $21.32 $30.32 +207.37%
December, 2026 $22.86 $22.39 $25.73 +178.82%

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Lexeo Therapeutics Inc (LXEO) is $25.18, with a high forecast of $31.92 and a low forecast of $18.44. This indicates an +207.08% increase from the last price of $8.20.
Month Average Low High Change from today's price
January, 2027 $22.89 $20.62 $25.46 +179.10%
February, 2027 $20.58 $20.10 $24.48 +150.96%
March, 2027 $20.18 $18.44 $21.93 +146.13%
April, 2027 $20.92 $19.72 $27.05 +155.17%
May, 2027 $23.99 $19.38 $26.51 +192.51%
June, 2027 $26.72 $22.91 $31.92 +225.85%
July, 2027 $24.51 $24.04 $27.30 +198.92%
August, 2027 $24.56 $22.29 $27.13 +199.55%
September, 2027 $22.78 $21.80 $26.17 +177.77%
October, 2027 $21.71 $19.96 $23.65 +164.76%
November, 2027 $22.48 $21.25 $28.61 +174.15%
December, 2027 $26.75 $20.94 $28.09 +226.22%

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2028

In 2028, Lexeo Therapeutics Inc (LXEO) is projected to reach an average price of $28.30, with a high projection of $35.12 and a low estimate of $21.48. This indicates an +245.11% rise from the last price of $8.20.
Month Average Low High Change from today's price
January, 2028 $28.34 $25.20 $33.52 +245.61%
February, 2028 $26.16 $25.69 $28.93 +219.03%
March, 2028 $27.47 $23.95 $28.80 +235.00%
April, 2028 $24.49 $23.51 $27.86 +198.66%
May, 2028 $23.57 $21.48 $25.37 +187.49%
June, 2028 $25.01 $22.50 $30.16 +205.04%
July, 2028 $28.34 $24.88 $29.67 +245.63%
August, 2028 $29.56 $26.80 $35.12 +260.45%
September, 2028 $28.12 $27.34 $30.30 +242.88%
October, 2028 $29.15 $25.61 $30.47 +255.54%
November, 2028 $26.21 $25.22 $29.55 +219.64%
December, 2028 $25.11 $23.00 $26.48 +206.20%

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2029

The 2029 price forecast for Lexeo Therapeutics Inc Stock (LXEO) is $31.19 on average, with a high prediction of $38.32 and a low estimate of $24.07. This represents an +280.38% increase from the previous price of $8.20.
Month Average Low High Change from today's price
January, 2029 $29.68 $24.07 $31.72 +261.95%
February, 2029 $30.72 $26.47 $36.72 +274.60%
March, 2029 $31.18 $30.17 $32.31 +280.30%
April, 2029 $29.77 $28.99 $31.95 +263.07%
May, 2029 $28.21 $27.28 $32.14 +244.06%
June, 2029 $27.93 $26.92 $30.35 +240.61%
July, 2029 $26.64 $24.52 $28.20 +224.91%
August, 2029 $31.25 $25.63 $33.27 +281.10%
September, 2029 $32.32 $28.05 $38.32 +294.10%
October, 2029 $31.88 $31.01 $33.92 +288.82%
November, 2029 $31.76 $28.94 $33.59 +287.30%
December, 2029 $29.90 $29.70 $33.81 +264.69%

Lexeo Therapeutics Inc Stock (LXEO) Price Forecast for 2030

Lexeo Therapeutics Inc Stock (LXEO) is expected to reach an average price of $33.78 in 2030, with a high forecast of $41.51 and a low forecast of $26.04. This signifies an +311.91% surge from the last price of $8.20.
Month Average Low High Change from today's price
January, 2030 $30.34 $28.63 $32.05 +269.96%
February, 2030 $29.68 $26.04 $30.35 +261.90%
March, 2030 $32.82 $27.19 $34.83 +300.25%
April, 2030 $33.91 $29.64 $39.91 +313.59%
May, 2030 $33.52 $32.65 $35.53 +308.75%
June, 2030 $33.42 $30.60 $35.24 +307.58%
July, 2030 $30.91 $30.56 $35.48 +277.01%
August, 2030 $31.29 $30.33 $32.25 +281.61%
September, 2030 $31.22 $27.56 $31.89 +280.70%
October, 2030 $32.35 $28.75 $36.38 +294.46%
November, 2030 $35.78 $31.22 $41.51 +336.33%
December, 2030 $35.15 $34.28 $37.14 +328.68%
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):